Uji klinis Alergi di California
7 studi untuk Alergi mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875Study of Oral Food Challenge Biomarkers (SAFER)
- Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research, Palo Alto
Menerima pesertaStudi observasional
12 Months – 17 Years · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07279467Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
- University of California, San Francisco, San Francisco
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06406114Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
- Orso Health, Inc., La Jolla
Menerima pesertaFase 4
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06834165Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
- Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Week – 90 Years · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT04828603Food Allergy Registry at a Single Site
- Stanford University, Palo Alto
Menerima pesertaStudi observasional
Usia 0 hingga 100 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT03539705Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.